As the VWF aptamer inhibits platelet recruitment and activation, PAI-1 levels may be reduced in thrombosis in the aptamer-treated canines, which may, in part, result in improved recanalization rates in arterial platelet-rich clots with AIS. This evidence concerns the gene SERPINE1 and deep vein thrombosis.